Zhi-yi Lv

Guangdong Provincial Key Laboratory Of Translational Medicine In Lung Cancer
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma.

Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma.

Journal: Clinical & translational immunology
Published: January 19, 2024

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer.

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer.

Journal: Journal of thoracic disease
Published: January 31, 2023

Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma.

Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma.

Journal: iScience
Published: January 30, 2023

The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients.

The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients.

Journal: Cancer treatment and research communications
Published: October 24, 2022

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.

Journal: Frontiers in immunology
Published: May 24, 2022

An integrated biomarker of PD-L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases.

An integrated biomarker of PD-L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases.

Journal: Thoracic cancer
Published: March 29, 2022

Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report.

Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report.

Journal: JTO clinical and research reports
Published: October 07, 2021

High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer.

High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer.

Journal: Thoracic cancer
Published: August 05, 2021

Timing and Origins of Local and Distant Metastases in Lung Cancer.

Timing and Origins of Local and Distant Metastases in Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 01, 2020

Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platform.

Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platform.

Journal: Translational cancer research
Published: April 30, 2020

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.

Journal: Thoracic cancer
Published: October 23, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026